Ketamine for PTSD: What the Research Shows and How It Fits With Therapy

What ketamine is and how it works in PTSD

Ketamine is a medicine first approved decades ago as an anesthetic. In low, sub-anesthetic doses given by IV (intravenous) infusion, it acts on the brain’s glutamate system — specifically on NMDA receptors — to rapidly increase the flexibility of neural circuits involved in fear and memory. That increase in neuroplasticity (the brain’s ability to form new connections) is thought to underlie the rapid symptom changes some patients report.

IV ketamine is not FDA-approved for depression, anxiety, or PTSD; it is used off-label for these conditions. “Off-label” means a clinician prescribes an approved medicine for a use the FDA has not specifically cleared, based on clinical judgment and research. If you are weighing your PTSD treatment options, it helps to know where ketamine fits in the ladder — after, not instead of, first-line care.

What research shows for ketamine in PTSD

In small studies and case series of off-label ketamine for PTSD, some patients reported rapid decreases in intrusive memories, nightmares, hypervigilance, and avoidance within hours to days of an infusion. The evidence base is limited: most studies are small, short-term, or in veterans, and larger controlled trials are still lacking. A consultation at NWCOA reviews your full history and trauma exposure before any off-label option is considered. Individual results may vary.

How ketamine fits with trauma-focused therapy

Trauma-focused therapy — including EMDR, trauma-focused CBT, and prolonged exposure — remains the first-line, evidence-based treatment for PTSD. Ketamine is not a replacement for that work. Instead, it is sometimes used off-label to reduce the intensity of intrusive symptoms so trauma-focused therapy can proceed. When paired with therapy as ketamine-assisted psychotherapy (KAP), the medicine session is followed by guided integration work. Learn more on our ketamine-assisted psychotherapy page.

Medication management is also part of the picture: the SSRI antidepressants sertraline and paroxetine are FDA-approved for PTSD. A clinician reviews your full medication history before any change; never start, stop, or change a medication on your own.

Ketamine vs Prism™ neurofeedback

Prism™ is an EEG-based neurofeedback device that is FDA-cleared in 2023 as an add-on treatment for PTSD symptoms in adults. It does not use ketamine; it trains the brain through feedback to help reduce the symptoms of trauma. It is not a standalone cure, and it is not a medication. Learn more on our Prism™ page.

IV ketamine, by contrast, is not FDA-approved for PTSD and is used off-label. Prism™ is the option at NWCOA with an FDA clearance aimed at PTSD itself, whereas ketamine targets symptom intensity as an off-label add-on. A consultation helps determine which — or which combination — fits your situation.

Ketamine vs SPRAVATO® when PTSD comes with depression

PTSD often co-occurs with depression. SPRAVATO® (esketamine) is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior — not for PTSD. It is given in the clinic under a REMS program with at least two hours of observation after each dose, and patients must not drive until the next day after a restful sleep.

When PTSD comes with depression, a clinician may address the depression component with SPRAVATO® or — for depression that has not improved enough on antidepressants — the SAINT® Neuromodulation System (FDA-cleared for major depressive disorder, not PTSD). Neither treats the PTSD itself, but reducing the depressive burden can make trauma-focused therapy more workable.

Who may be a fit for ketamine for PTSD

Off-label ketamine is typically considered only after first-line care — trauma-focused therapy and medication management — has been tried and not produced enough relief. It is not a first choice for new PTSD, and it is not for everyone: a full evaluation reviews your trauma history, other conditions, and risks.

Serving Broward and patients who travel

We see patients from across Broward County and south Palm Beach County at one clinic in Coral Springs, at 9734 W Sample Rd, Suite B. Patients from Fort Lauderdale, Boca Raton, Pompano Beach, and Parkland reach us via I-95 or the Florida Turnpike to Sample Rd. We also see adults who travel from other parts of Florida and other states for a ketamine series. If you are traveling from outside Broward County, our team can walk you through scheduling during your free consultation.

IV ketamine vs SPRAVATO® vs Prism™ for PTSD

Frequently asked questions

Cited research

1. Feder A, Parides MK, Murrough JW, et al. "Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial." JAMA Psychiatry. 2014;71(6):681–688. doi.org/10.1001/jamapsychiatry.2014.62
2. Pradhan B, Nachrein R, Phillips M, et al. "A randomized, controlled trial of ketamine-assisted psychotherapy for refractory chronic posttraumatic stress disorder (KAP-PTSD)." Chronic Stress. 2024;8. doi.org/10.1177/24705470241271342
3. Nicholson TR, Williams A, Sankar S, et al. "Systematic review and meta-analysis of ketamine for PTSD." BJPsych Open. 2024;10(1):e34. doi.org/10.1192/bjo.2023.96
4. Davis LL, Clark DM, Kramer GL, et al. "Sertraline for the treatment of chronic posttraumatic stress disorder." J Clin Psychiatry. 2001;62 Suppl 17:26–32. ncbi.nlm.nih.gov